Is radioiodine ablation with 1.1 GBq (30 mCi) 131I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study-Reference-Cited by-同舟云学术

Is radioiodine ablation with 1.1 GBq (30 mCi) 131I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study

Published:2023-03-29 Issue:3 Volume:80 Page:606-611
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Ilera Verónica^ORCID,Califano Inés^ORCID,Cavallo Andrea^ORCID,Faure Eduardo^ORCID,Vázquez Adriana^ORCID,Pitoia Fabián^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-023-03306-w.pdf

Reference34 articles.

1. B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016)

2. G.K. Markantes, M. Karakioulaki, S. Papanikolopoulou et al. Improving the prediction of persistent and recurrent differentiated thyroid cancer using the American Thyroid Association 2015 risk stratification system. Hormones 20, 761–768 (2021)

3. F. Pitoia, I. Califano, A. Vázquez et al. Consenso intersocietario sobre tratamiento y seguimiento de pacientes con cáncer diferenciado de tiroides. Rev. Arg. Endocrinol. Metab. 51(2), 85–118 (2014)

4. R.M. Tuttle, H. Tala, J. Shah et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioiodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association guidelines. Thyroid 20(12), 1341–1349 (2010)

5. F. Vaisman, H. Tala, R. Grewal, R.M. Tuttle, In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21(12), 1317–1322 (2011)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Analysis of 131I Efficacy After Papillary Thyroid Carcinoma Surgery Based on CT Radiomics;The Journal of Clinical Endocrinology & Metabolism;2024-05-27

2. Dynamic risk assessment in patients with differentiated thyroid cancer;Reviews in Endocrine and Metabolic Disorders;2023-11-28